Fingolimod Hydrochloride

CD8a molecule ; Homo sapiens







10 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35197967 Cytotoxic B Cells in Relapsing-Remitting Multiple Sclerosis Patients. 2022 1
2 35288472 Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients. 2022 Apr 1 1
3 32034063 Fingolimod Profoundly Reduces Frequencies and Alters Subset Composition of Circulating T Follicular Helper Cells in Multiple Sclerosis Patients. 2020 Mar 1 1
4 33007647 Selective modulation of trans-endothelial migration of lymphocyte subsets in multiple sclerosis patients under fingolimod treatment. 2020 Dec 15 3
5 30852478 Efficacy of fingolimod combined with alteplase in acute ischemic stroke and rehabilitation nursing. 2019 Jan 1
6 30537798 Characterization of CD4+ and CD8+ T Cell Subsets and Interferon Regulatory Factor 4 (IRF4) in MS Patients Treated with Fingolimod (FTY-720): A Follow-up Study. 2018 Aug 12 3
7 27631876 High-Resolution Expression Profiling of Peripheral Blood CD8+ Cells in Patients with Multiple Sclerosis Displays Fingolimod-Induced Immune Cell Redistribution. 2017 Sep 3
8 28155899 Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis. 2017 Feb 3 1
9 26683421 Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes. 2016 Apr 1
10 24740509 Tissue-resident exhausted effector memory CD8+ T cells accumulate in the retina during chronic experimental autoimmune uveoretinitis. 2014 May 15 2